Treace Medical Concepts, Inc. (TMCI)
4.63
-0.18
(-3.74%)
USD |
NASDAQ |
Sep 08, 16:00
4.645
+0.02
(+0.32%)
After-Hours: 20:00
Treace Medical Concepts Debt to Equity Ratio : 1.078 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.078 |
| March 31, 2026 | 0.9276 |
| December 31, 2025 | 0.8229 |
| September 30, 2025 | 0.789 |
| June 30, 2025 | 0.7181 |
| March 31, 2025 | 0.6585 |
| December 31, 2024 | 0.617 |
| September 30, 2024 | 0.6684 |
| June 30, 2024 | 0.6229 |
| March 31, 2024 | 0.5547 |
| December 31, 2023 | 0.5097 |
| September 30, 2023 | 0.5113 |
| June 30, 2023 | 0.4895 |
| March 31, 2023 | 0.4396 |
| Date | Value |
|---|---|
| December 31, 2022 | 1.133 |
| September 30, 2022 | 1.157 |
| June 30, 2022 | 0.9867 |
| March 31, 2022 | 0.5145 |
| December 31, 2021 | 0.3155 |
| September 30, 2021 | 0.3011 |
| June 30, 2021 | 0.2845 |
| March 31, 2021 | -42.74 |
| December 31, 2020 | 39.92 |
| September 30, 2020 | |
| June 30, 2020 | |
| March 31, 2020 | |
| December 31, 2019 | 6.081 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Tactile Systems Technology, Inc. | 0.0642 |
| Abbott Laboratories | 0.638 |
| AngioDynamics, Inc. | 0.0641 |
| Alphatec Holdings, Inc. | 52.37 |
| AtriCure, Inc. | 0.1437 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 181.06M |
| Total Liabilities (Quarterly) | 113.32M |
| Shareholders Equity (Quarterly) | 67.74M |
| Current Ratio | 2.903 |
| Net Debt Paydown Yield | -0.28% |